Find a Clinical Trial

Is a clinical trial right for you? Search our database to find studies for which you may be eligible.

Browse All Clinical Trials

Viewed View Trial

Pilot Trial of Ultra-Hypofractionated Radiation in Early Prostate Cancer

Study Type: Treatment

Phase: Feasibility/Pilot

NCTID: NCT03486821

Principal Investigator: Xinglei Shen

Viewed View Trial

PREcision DIagnostics in Prostate Cancer Treatment PREDICT

Study Type: Treatment

Phase: II

NCTID: NCT06632977

Principal Investigator: Elizabeth Wulff-Burchfield

Viewed View Trial

A Multi-Center, Prospective, Observational Study of Patients Being Treated with ORGOVYX

Study Type: Other

Phase: N/A

NCTID: NCT05467176

Principal Investigator: Xinglei Shen

Viewed View Trial

Weight management Aimed to Reduce Risk and Improve Outcomes from Radical Prostatectomy: WARRIOR

Study Type: Basic Science

Phase: N/A

NCTID: NCT03261271

Principal Investigator: Jill Hamilton-Reeves

Viewed View Trial

Cabazitaxel with Abiraterone versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial

Study Type: Treatment

Phase: II

NCTID: NCT03419234

Principal Investigator: Rahul Parikh

Viewed View Trial

Phase III Study, CONTACT-02: A Phase III, Randomized, Open-Label, Controlled Study of Cabozantinib XL 184 in Combination with Atezolizumab vs Second Novel Hormonal Therapy NHT in Subjects with Metastatic Castration-Resistant Prostate Cancer

Study Type: Treatment

Phase: III

NCTID: NCT04446117

Principal Investigator: Rahul Parikh

Viewed View Trial

A Phase I Open-Label, Multi-Center Study of PSMA Targeted Genetically Modified Chimeric Antigen Receptor T Cells in Patients with Metastatic Castration Resistant Prostate Cancer

Study Type: Treatment

Phase: I

NCTID: NCT04227275

Principal Investigator: Rahul Parikh

Viewed View Trial

A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study ICON study number: 0798/0661

Study Type: Treatment

Phase: II

NCTID: NCT02960022

Principal Investigator: Rahul Parikh

Viewed View Trial

Quantifying Optimal Relugolix Duration with Radiation in High Risk Prostate Cancer QURE-PC

Study Type: Treatment

Phase: II

NCTID: NCT06129851

Principal Investigator: Xinglei Shen

Viewed View Trial

STEEL: A Randomized Phase II Trial of Salvage Radiotherapy with Standard vs Enhanced Androgen Deprivation Therapy with Enzalutamide in Patients with Post-Prostatectomy PSA Recurrences with Aggressive Disease Features

Study Type: Treatment

Phase: II

NCTID: NCT03809000

Principal Investigator: Xinglei Shen